Literature DB >> 19782378

European Charcot Foundation Lecture: the natural history of multiple sclerosis and gender.

A D Sadovnick1.   

Abstract

The role of gender in the natural history of multiple sclerosis (MS) is multi-faceted. Earliest debate on this topic was about the sex ratio (female:male) among affected individuals. It was only clearly shown within the last 4 decades that females are more often affected. The sex ratio continues to intrigue researchers. An observed increase in the sex ratio among more recently born MS patients has now been taken as a clear indication that the rate of MS is truly increasing in many geographical areas. This temporal increase in females has been relatively rapid, implicating environmental rather than genetic risk factors. Gender issues in MS expand beyond the scope of sex ratio. Gender has an impact on various aspects of MS, including age of onset, "parent-of-origin" effects (seen in half-siblings, twin sibships, avuncular pairs, transmission of HLA haplotype), recurrence risks for relatives of MS patients and the topic of reproduction when one parent has MS. Gender issues can also confound data collection and analyses with respect to studies on comorbidity, risk factors and family history. In fact, it has now been clearly validated and quantified that among persons with MS, there is a sex-specificity of recall and reporting bias as well a greater female awareness of medical history.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19782378     DOI: 10.1016/j.jns.2009.09.005

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  19 in total

1.  PD-1 Interaction with PD-L1 but not PD-L2 on B-cells Mediates Protective Effects of Estrogen against EAE.

Authors:  Sheetal Bodhankar; Danielle Galipeau; Arthur A Vandenbark; Halina Offner
Journal:  J Clin Cell Immunol       Date:  2013-05-06

2.  Progesterone treatment reduces disease severity and increases IL-10 in experimental autoimmune encephalomyelitis.

Authors:  M A Yates; Y Li; P Chlebeck; T Proctor; A A Vandenbark; H Offner
Journal:  J Neuroimmunol       Date:  2010-02-11       Impact factor: 3.478

3.  Contribution of GPR30 for 1,25 dihydroxyvitamin D₃ protection in EAE.

Authors:  Sandhya Subramanian; Lisa M Miller; Marjorie R Grafe; Arthur A Vandenbark; Halina Offner
Journal:  Metab Brain Dis       Date:  2011-10-13       Impact factor: 3.584

4.  The Sexual Dimorphism in Cerebrospinal Fluid Protein Content Does Not Affect Intrathecal IgG Synthesis in Multiple Sclerosis.

Authors:  Massimiliano Castellazzi; Caterina Ferri; Ginevra Tecilla; André Huss; Paola Crociani; Gaetano Desina; Gianvito Barbella; Alice Piola; Samantha Permunian; Makbule Senel; Maurizio Leone; Hayrettin Tumani; Maura Pugliatti
Journal:  J Pers Med       Date:  2022-06-16

Review 5.  The Role of Transcranial Magnetic Stimulation as a Surrogate Marker of Disease Activity in Patients with Multiple Sclerosis: A Literature Review.

Authors:  Muhannad M Alsharidah; Mohammad Uzair; Sarah S Alseneidi; Afnan A Alkharan; Reem Fahd Bunyan; Shahid Bashir
Journal:  Innov Clin Neurosci       Date:  2022 Jan-Mar

6.  GPR30, but not estrogen receptor-alpha, is crucial in the treatment of experimental autoimmune encephalomyelitis by oral ethinyl estradiol.

Authors:  Melissa A Yates; Yuexin Li; Peter J Chlebeck; Halina Offner
Journal:  BMC Immunol       Date:  2010-04-19       Impact factor: 3.615

7.  Sex-specific differences in retinal nerve fiber layer thinning after acute optic neuritis.

Authors:  Fiona Costello; William Hodge; Y Irene Pan; Jodie M Burton; Mark S Freedman; Peter K Stys; Jessie Trufyn; Randy Kardon
Journal:  Neurology       Date:  2012-10-17       Impact factor: 9.910

8.  Geographical variations in sex ratio trends over time in multiple sclerosis.

Authors:  Maria Trojano; Guglielmo Lucchese; Giusi Graziano; Bruce V Taylor; Steve Simpson; Vito Lepore; Francois Grand'maison; Pierre Duquette; Guillermo Izquierdo; Pierre Grammond; Maria Pia Amato; Roberto Bergamaschi; Giorgio Giuliani; Cavit Boz; Raymond Hupperts; Vincent Van Pesch; Jeannette Lechner-Scott; Edgardo Cristiano; Marcela Fiol; Celia Oreja-Guevara; Maria Laura Saladino; Freek Verheul; Mark Slee; Damiano Paolicelli; Carla Tortorella; Mariangela D'Onghia; Pietro Iaffaldano; Vita Direnzo; Helmut Butzkueven
Journal:  PLoS One       Date:  2012-10-25       Impact factor: 3.240

9.  The DNA copy number of human endogenous retrovirus-W (MSRV-type) is increased in multiple sclerosis patients and is influenced by gender and disease severity.

Authors:  Marta Garcia-Montojo; María Dominguez-Mozo; Ana Arias-Leal; Ángel Garcia-Martinez; Virginia De las Heras; Ignacio Casanova; Raphaël Faucard; Nadège Gehin; Alexandra Madeira; Rafael Arroyo; François Curtin; Roberto Alvarez-Lafuente; Hervé Perron
Journal:  PLoS One       Date:  2013-01-07       Impact factor: 3.240

10.  Interleukin-6 gene promoter-572 C allele may play a role in rate of disease progression in multiple sclerosis.

Authors:  Jun Yan; Jia Liu; Clement Yihao Lin; Peter A Csurhes; Michael P Pender; Pamela A McCombe; Judith M Greer
Journal:  Int J Mol Sci       Date:  2012-10-22       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.